loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 17060 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Teva Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TEVA BRANDED PHARM (1)

    filter

    01 TABLET;ORAL-28 (1)

    filter

    01 RX (1)

    filter

    01 NOR-QD (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    NORETHINDRONE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL-28
    0.35MG
    1982-01-01
    17060
    NOR-QD
    RX
    Yes
    AB1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 17060

    Looking for FDA Orange Book APPLICATION 17060 1

    19

    Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is NORETHINDRONE, with a corresponding application number 17060.

    Regulatory Information RX

    With a dosage strength 0.35MG

    Dosage Form Route TABLET; ORAL-28

    Reference Listed Drug Yes

    Approved since 1982-01-01

    Therapeutic Equivalence (TE) Code AB1

    Post Enquiry
    POST ENQUIRY